Non Hodgkin Lymphoma Clinical Trial

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

Summary

The purpose of this study is to monitor physiological and molecular changes during and following CAR-T cancer cell therapy, towards improved management of adverse events including Cytokine Release Syndrome and neurotoxicity.

Our study aims are to improved early detection and precise management of adverse events for patients receiving Chimeric antigen receptor T- cell (CAR-T):

To assess the feasibility, including accuracy, usability, and usefulness of wearable sensors in CAR-T patients.
To generate comprehensive multiomic profile analysis following CAR-T therapy.
To perform integrated analysis of wearables sensor data, omics data, and symptom/clinical data.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Participant must be in the process of undergoing cancer cell therapy at Stanford University.

Adults > 18 years
Any cell target may be used. (e.g. CD19, CD22, Bispecific CD19/22, Bispecific CD19/20, etc.)
English speaking
Assessed ability for caregiver/patient to use wearable devices and independently perform blood microsample collection

Exclusion Criteria:

In the investigator's judgment, the subject is unlikely to comply with all protocolrequired study visits or procedures.

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

15

Study ID:

NCT05123001

Recruitment Status:

Recruiting

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford University
Palo Alto California, 94305, United States More Info
Sharan Claire
Contact
650-721-4091
[email protected]
Surbhi Sidana, MD
Principal Investigator
Michael P. Snyder, PhD
Sub-Investigator
David Miklos, MD, PhD
Sub-Investigator
Matthew Frank, MD, PhD
Sub-Investigator
Theresa Latchford, MS
Sub-Investigator
Ryan Kellogg, PhD
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

15

Study ID:

NCT05123001

Recruitment Status:

Recruiting

Sponsor:


Stanford University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.